Clinical Trial Update: A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules [Phase 2]

View source ↗

Summary

A Phase 2 multiple-dose study evaluated safety, tolerability, and pharmacokinetics of risperidone extended-release capsules in schizophrenia and schizoaffective…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Risperidone extended-release capsules (risperidone)

Snippet

Sponsor: Lyndra Inc. | Conditions: Schizophrenia Schizoaffective | Phase 2 | Status: COMPLETED | Results posted: 2023-02-08